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httcense.Abstract Background: In recent years, dual-control ventilation has been introduced in an attempt
to combine the attributes of volume ventilation (constant tidal volume and minute ventilation) with
the attributes of pressure ventilation (rapid, variable ﬂow and reduced work of breathing). Pressure-
regulated volume control (PRVC) is kind of dual-controlled ventilation in which the ventilator
attempts to achieve the volume target using a pressure- control gas delivery format at the lowest
possible airway pressure.
Aim of the work: This work was planned to evaluate the outcome of PRVC ventilation in the
management of ARF of different pulmonary diseases in terms of efﬁcacy, and predictors of success.
Subjects and methods: The study comprised 79 patients (45 males and 34 females) with acute
respiratory failure (ARF) of different pulmonary disorders and required mechanical ventilation.
21 patients (26.6%) were presented with type I RF and 58 (73.4%) were presented with type II
RF. Cases of type II RF included 32 COPD patients with acute on top of chronic respiratory failure
(RF), 13 obesity hypoventilation syndrome associated with obstructive sleep apnea syndrome
(OHS-OSAS) patients with acute on top of chronic RF and 13 bronchiectasis patients with acute
on top of chronic RF. Type I RF cases included 16 cases of pneumonia with ARF and 5 pulmonary
embolism cases with ARF. All patients were intubated and ventilated using PRVC ventilation. Reg-
ular review of the clinical condition (with special consideration of vital signs and Glasgow ComaC, volume controlled; PRVC,
F, acute respiratory failure;
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152 M.E. Abou Shehata et al.Score) and blood gas analysis was done to all patients after 1 and 2 h of invasive ventilation and 6 h
at varying interval thereafter till the time of weaning with recording of development of any organ
dysfunction, duration of mechanical ventilation and length of hospital stay.
Results: The outcome showed (62%) survival and (38%) mortality. MODS have developed in
49.3% cases. There was no signiﬁcant difference in the outcome of PRVC as regard survival
between different etiologies of respiratory failure; also there was no signiﬁcant difference as regard
survival with the use of PRVC between type I and type II respiratory failure. There were signiﬁcant
improvement of respiratory rate and Glasgow Coma Score following mechanical ventilation with
PRVC mode after extubation. There were signiﬁcant improvement of arterial blood gases after
1 h, 2 h, 2nd day, 3rd day of using PRVC with gradual reduction of the used FiO2 in the same per-
iod. There were signiﬁcant more worse hypercapnia and higher bicarbonate level on admission in
died than survived cases. There were signiﬁcant longer duration of PRVC and overall mechanical
ventilation days in died than survived cases. Co-morbid renal impairment was signiﬁcantly higher in
died than survived cases. There were signiﬁcant more development of MODS in died than survived
cases, with signiﬁcant more presentation of cardiovascular and renal failure during PRVC.
Conclusion: PRVC ventilation improves oxygenation parameters in ARF of different etiologies
and is equally effective in management of ARF of different pulmonary disorders. The most impor-
tant predictors for mortality were development of MODS and prolonged duration of MV as
detected by logistic regression analysis.
ª 2012 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier B.V.
Open access under CC BY-NC-ND license.Introduction
Conventional ventilation may lead to overdistention of the nor-
mally functioning lung while expanding collapsed parts. Thus,
mechanical ventilation may exacerbate the pulmonary pathol-
ogy and/or delay recovery [1]. Since the late 1960s, mechanical
ventilation has been accomplished primarily using volume con-
trolled (VC) ventilation. While VC ventilation allows a set tidal
volume to be guaranteed, it could bring excessive airway pres-
sures thatmay lead to barotrauma in patients with acute lung in-
jury. With increased knowledge related to ventilator – induced
lung injury, pressure controlled (PC) ventilation has been fre-
quently applied to these patients [2]. Pressure modes of invasive
mechanical ventilation generate a tidal breath bydeliveringpres-
sure over time. Empiric management with a pressure mode may
achieve the goals of patient-ventilator synchrony, effective respi-
ratory system support, adequate gas exchange, and limited ven-
tilator-induced lung injury [3]. But PC ventilation has a
disadvantage of variable tidal volume delivery as pulmonary
impedance changes [2].
In recent years, dual-control (adaptive pressure control)
modes has been introduced in an attempt to combine the attri-
butes of volume ventilation with the attributes of pressure ven-
tilation [4] to avoid both the high peak airway pressures of
volume ventilation and also the varying tidal volume that
may occur with pressure ventilation [5].
Pressure-regulated volume control (PRVC) mode, also
known as adaptive pressure-controlled continuous mandatory
ventilation (CMV) or volume control plus (VC+) [3,4], is a
kind of dual-control ventilation that uses tidal volume as a
feed back control for continuously adjusting the pressure limit
[2]. In PRVC, all breaths are mandatory, the rate is ﬁxed, and
the inspiratory pressure is varied to maintain a preset tidal vol-
ume [5]. PRVC is used during lung-protective ventilation be-
cause the high, variable, peak inspiratory ﬂow rate may
reduce patient work of breathing more than the ﬁxed peak
inspiratory ﬂow rate of volume-control ventilation [6].Aim of the work
This work was planned to evaluate the outcome of PRVC ven-
tilation in the management of ARF of different pulmonary dis-
eases in terms of efﬁcacy, and predictors of success.
Subjects and methods
The study was approved by the Ethic Committee fromMedical
Research Ethical Committee, Mansoura University. The study
comprised 79 patients (45 males and 34 females) with acute
respiratory failure (ARF) due to pulmonary disorders. Patients
were admitted to the Respiratory Intensive Care Unit of Tho-
racic Medicine Department, Mansoura University Hospitals.
The mean age of studied cases was (60.24 ± 15.06) with age
range (25–85 years). 21 patients (26.6%) were presented with
type I RF and 58 (73.4%) were presented with type II RF,
all patients were in need for invasive mechanical ventilation.
Cases of type II RF included 32 COPD patients with acute
on top of chronic respiratory failure (RF), 13 obesity hypoven-
tilation syndrome associated with obstructive sleep apnea syn-
drome (OHS-OSAS) patients with acute on top of chronic RF
and 13 bronchiectasis patients with acute on top of chronic
RF. Type I RF cases included 16 cases of pneumonia with
ARF and 5 pulmonary embolism cases with ARF.
The inclusion criteria was the presence of acute respiratory
failure, with a partial pressure of arterial oxygen (PaO2;
mmHg) /FiO2 ratio of <300 [7]. Patients with extra-pulmon-
ary causes of ARF and less than 18 years old were excluded.
The patients were subjected to thorough history taking and
physical examination, chest X-ray, routine liver function tests,
serum creatinine, complete blood picture, and recording of co-
morbid condition of patients.
All patients were intubated and ventilated using ‘‘Inspira-
tion Events Ventilator’’, PRVC ventilation was applied with
the following variables were instituted for both groups during
ventilation: tidal volume (VT) 5–8 ml/kg, a respiratory rate to
Table 2 Follow up vital signs following mechanical ventila-
tion with PRVC.
Pre intubation After extubation P value
GCS 5.15 ± 1.86 14.28 ± 2.68 <0.001
RR 19.78 ± 8.57 13.39 ± 7.51 <0.001
HR* 102 (0–167) 102 (0–152) 0.795
MAP* 85 (0–140) 80 (0– 120) 0.262
GCS= Glasgow Coma Score, RR= respiratory rate, HR= heart
rate, MAP= mean arterial pressure.
There were signiﬁcant improvement of respiratory rate and Glas-
gow Coma Score following mechanical ventilation with PRVC
mode after extubation.
* Median (min–max) and Mann–Whitney U test was used for data
with non-parametric distribution.
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(PaCO2), inspiratory time 30% (no pause) and constant
PEEP [7]. Settings were tailored according to clinical condi-
tion indicating mechanical ventilation. The inspiratory time
% was increased when needed to correct hypoxemia with
least FiO2. The I:E ratio is adjusted on the basis of the respi-
ratory time constant to allow for effective emptying of the
lungs in expiration and to avoid intrinsic positive end expira-
tory pressure (PEEP) [8]. Midazolam (0.1 mg/kg) was given
for sedation on daily interrupted regimens.
Regular review of the clinical condition (with special con-
sideration of vital signs and Glasgow Coma Score (GCS) and
blood gas analysis were done to all patients after 1 and 2 h of
invasive ventilation and 6 h and at varying interval thereafter
till the time of weaning with recording the development of
any organ dysfunction, duration of mechanical ventilation,
length of ICU and hospital stay. Multiple organ dysfunction
syndrome (MODS) was deﬁned as progressive but reversible
dysfunction of at least two organs that arises from an acute
disruption of normal homeostasis, requiring intervention [9].
Weaning was attempted from the ﬁrst day of ventilation when
the patient ventilation parameters fulﬁll the criteria for wean-
ing described by Corrado et al. [10].Table 1 Patients description.
Items
Age
Mean ± SD 60.24 ± 15.06
Range 25–85
Sex
Male No (%) 45 (57%)
Female No (%) 34 (43%)
Type of respiratory failure
Type I No (%) 21 (26.6%)
Type II No (%) 58 (73.4%)
Aetiology
COPD No (%) 32 (40.5%)
OHS-OSAS No (%) 13 (16.5%)
Bronchiactesis No (%) 13 (16.45%)
Pneumonia No (%) 16 (20.3%)
PE No (%) 5 (6.3%)
MV days
Mean ± SD 4.08 ± 3.29
Median (min–max) 3 (1–15)
PRVC days
Mean ± SD 2.65 ± 2.60
Median (min – max) 2 (1.0–13.0)
Weaning days
Mean ± SD 1.55 ± 0.81
Median (min–max) 1 (0.5–4.0)
ICU days
Mean ± SD 6.04 ± 3.83
Median (min–max) 5 (1–22)
Hospital days
Mean ± SD 7.07 ± 4.25
Median (min–max) 7 (1–22)Statistical analysis
Data was analyzed using SPSS (Statistical Package for Social
Sciences) version 15. Qualitative data was presented as number
and percent. Comparison between groups was done by Chi-
Square test. Quantitative data was tested for normality by
Kolmogrov–Smirnov test. Normally distributed data was pre-
sented as mean ± SD. Student t-test was used to compare be-
tween two groups. Non-parametric data was presented as
(minimum – maximum) and median using Mann–Whitney test
for comparison between two groups. P 6 0.05 was considered
to be statistically signiﬁcant. Statistically signiﬁcant variables
were then entered into logistic regression analysis to determine
the most important predictors of success (see Tables 1–10).
Results
The outcome showed (62%) survival and (38%) mortality.
There was no signiﬁcant difference in the outcome of PRVC
as regard survival between different etiologies of respiratory
failure, also there was no signiﬁcant difference as regard sur-
vival with the use of PRVC between type I and type II respira-
tory failure (Tables 4 and 5). There were signiﬁcant
improvement of respiratory rate and Glasgow Coma Score fol-
lowing mechanical ventilation with PRVC mode after extuba-
tion (Table 2). There were signiﬁcant improvement of arterial
blood gases after 1h, 2h, 2nd day, 3rd day of using PRVC with
gradual reduction of the used FiO2 in the same period (Ta-
ble 3). There were no signiﬁcant difference between survived
and died cases as regard admission blood gases and vital signs,
apart from signiﬁcant more worse hypercapnia and higher
bicarbonate level at admission in died than survived cases (Ta-
ble 6). Co-morbid diseases were present in 56 cases (70.88%),
there was signiﬁcant more co-morbid renal impairment in died
than survived cases. MODS have developed in 39 cases
(49.3%). There were signiﬁcant more development of MODS
in died than survived cases, with signiﬁcant more presentation
of cardiovascular and renal failure during PRVC (Table 7).
There were signiﬁcant longer duration of PRVC and overall
mechanical ventilation days in died than survived cases
(Table 8).There were signiﬁcant lower hemoglobin, signiﬁcant
higher WBCs count, serum AST and serum creatinine at
admission in died than survived cases (Table 9). The most
important predictors for mortality were development of
Table 3 Follow up of blood gases during PRVC.
Pre-intubation 1 h 2 h 2nd day 3rd day
pH 7.14 ± 0.12 7.28 ± 0.25 7.33 ± 0.10 7.38 ± 0.10 7.37 ± 0.07
P< 0.001 P< 0.001 P< 0.001 P< 0.001
SaO2 77.62 ± 11.07 88.67 ± 10.71 89.98 ± 8.81 89.24 ± 9.94 90.92 ± 8.12
P< 0.001 P< 0.001 P< 0.001 P< 0.001
PaO2 51.27 ± 10.40 74.25 ± 20.64 74.16 ± 20.03 70.85 ± 22.93 76.02 ± 22.36
P< 0.001 P< 0.001 P< 0.001 P< 0.001
PaCO2 83.71 ± 28.11 62.66 ± 19.77 56.18 ± 15.02 49.37 ± 14.91 54.82 ± 13.58
P< 0.001 P< 0.001 P< 0.001 P< 0.001
HCO3 27.62 ± 8.81 27.79 ± 8.93 28.26 ± 6.48 28.26 ± 6.94 30.22 ± 7.12
P= 0.852 P= 0.431 P= 0.913 P= 0.005
FiO2 56.38 ± 19.10 50.23 ± 9.20 47.84 ± 3.92 48.44 ± 7.53 47.66 ± 3.76
P 6 0.001 P< 0.001 P= 0.001 P= 0.017
P value represents the signiﬁcance of comparison between pre-intubation and after 1 h, 2 h, 2nd day and 3rd day of ventilation P< 0.05
signiﬁcant. There were signiﬁcant improvement of arterial blood gases after 1 h, 2 h, 2nd day and 3rd day of PRVC with gradual reduction of
FiO2 in the same period.
Table 4 Comparison between type I and type II respiratory
failure as regard survival.
Survived Died P value
N= 49 (62%) N= 30 (38%)
Type I 10 (20.4%) 11 (36.7%) 0.112
Type II 39 (79.6%) 19 (63.3%)
*Chi-square test was done, P< 0.05 signiﬁcant.
There was no signiﬁcant difference as regard survival with the use
of PRVC between type I and type II respiratory failure.
Table 5 Outcome of PRVC according to aetiology of
respiratory failure.
Items Survived Died P value
N= 49 (62%) N= 30 (38%)
COPD 22 (44.9%) 10 (33.33%) 0.101
OHS-OSAS 9 (18.4%) 4 (13.33%)
Bronchiectasis 8 (16.3%) 5 (16.66%)
Pneumonia 7 (14.3%) 9 (30%)
PE 3 (6.1%) 2 (6.7%)
*Chi-square test was done, P< 0.05 signiﬁcant.
There was no signiﬁcant difference in the outcome of PRVC as
regard survival between different aetiologies of respiratory failure.
Table 6 Comparison between survived and died cases as
regard admission vital signs and blood gases.
Items Survived (No = 49) Died (No = 30) P value
GCS 4.94 ± 1.66 4.86 ± 2.92 0.894
RR 19.88 ± 7.74 19.63 ± 9.91 0.903
*HR 104.5 (0–143) 100 (0–167) 0.906
*MAP 95 (0–140) 25 (0–100) 0.004
pH 7.15 ± 0.14 7.14 ± 0.11 0.945
SaO2 79.49 ± 12.03 76.47 ± 10.40 0.241
PaO2 52.37 ± 11.90 50.59 ± 9.43 0.463
PaCO2 74.74 ± 32.77 89.21 ± 23.54 0.040
HCO3 24.93 ± 9.19 29.21 ± 8.26 0.037
GCS = Glasgow Coma Score, RR= respiratory rate, HR= heart
rate, MAP=mean arterial pressure.
There were signiﬁcant more worse hypercapnia, higher bicarbonate
level and lower MAP at admission in died than survived cases.
* Median (min–max) and Mann–Whitney U test was used for data
with non-parametric distribution, P< 0.05 signiﬁcant.
154 M.E. Abou Shehata et al.MODS and prolonged duration of MV as detected by logistic
regression analysis (Table 10).
Discussion
In recent years, dual-control modes has been introduced in an
attempt to combine the attributes of volume ventilation with
the attributes of pressure ventilation [4], to avoid both the high
peak airway pressures of volume ventilation and also the vary-
ing tidal volume that may occur with pressure ventilation.Pressure-regulated volume control (PRVC) mode is a kind of
dual-control ventilation that uses tidal volume as a feed back
control for continuously adjusting the pressure limit [5].
No single mode has consistently demonstrated superiority
in clinical trials; however, empiric management with a pressure
mode including PRVC may achieve the goals of patient-venti-
lator synchrony, effective respiratory system support, adequate
gas exchange, and limited ventilator-induced lung injury [3].
To date there have been no randomized controlled trials with
large numbers of patients to evaluate the use of dual modes
ventilation in the intensive care unit or during general anesthe-
sia [11].
This work was planned to evaluate the outcome of PRVC
ventilation in the management of ARF of different pulmonary
diseases in terms of efﬁcacy, and predictors of success.
In this work survival after PRVC was 62% (49/79) which
was nearby to that found by Guldager et al. [7] who found
54.54% (12/22) survival after PRVC in ARF of different etiol-
Table 8 Comparison between survived and died cases as
regard mechanical ventilation days, ICU and hospital duration.
Items Survived (No = 49) Died (No = 30) P value*
Median (min–max) Median (min–max)
MV days 3 (1–11) 4.5 (1–15) 0.009
PRVC days 2 (1–10) 2 (1–13) 0.035
Weaning days 1 (0.5–3) 1 (1–4) 0.578
Sedation days 1 (1–3) 1 (1–3) 0.861
ICU days 5 (2–15) 5 (1–22) 0.803
Hospital days 7 (3–21) 5.5 (1–22) 0.170
There were signiﬁcant longer duration of PRVC and overall
mechanical ventilation days in died than survived cases.
* Median (min–max) and Mann–Whitney U test was used for data
with non-parametric distribution, P< 0.05 signiﬁcant.
Table 9 Comparison between survived and died cases as
regard baseline laboratory ﬁndings.
Items Survived Died P value
HGB 12.51 ± 2.40 11.28 ± 1.96 0.04
RBCs 5.08 ± 1.42 4.68 ± 1.27 0.287
WBCs* 9.6 (4.8–67) 14 (5.6–37) 0.002
Platelet* 206 (95–376) 222.5 (57–347) 0.644
ALT* 33 (15–688) 33 (15–1282) 1.0
AST* 30 (21–378) 56 (26–288) 0.028
Albumin 3.44 ± 0.75 3.42 ± 0.57 0.937
Creatininea 1.2 (0.6–9.7) 1.7 (0.7–4.9) 0.006
There were signiﬁcant lower hemoglobin, signiﬁcant higher WBCs
count, serum AST and serum creatinine at admission in died than
survived cases.
* Median (min–max) and Mann–Whitney U test was used for data
with non-parametric distribution, P< 0.05 signiﬁcant.
Table 10 Logistic regression analysis of outcome predictors.
Regression
coeﬃcient
Odds ratio 95% CI P value
Lower Upper
MODS 3.362 28.845 6.169 134.880 <0.001*
MV days 0.184 0.832 0.702 0.985 0.033*
* P< 0.05 signiﬁcant.
Signiﬁcant variables in univariate analysis were entered into logistic
regression model and only MODS and MV days were the most
signiﬁcant predictors of success. The odds ratio was 28.845 for
MODS; its P value was 0.001and it was 0.832; its P value was 0.033
for MV days.
Table 7 Comparison between survived and died cases as regard demographic data, co-morbidity and MODS.
Items Survived (No = 49) Died (No = 30) P value
Age 60.0 ± 14.49 60.63 ± 15.48 0.86*
Sex (M/F) 30/19 15/15 0.33
Co-morbidity 33 (67.3%) 23 (76.7%) 0.376
HTN 29 (59.2%) 15 (50%) 0.425
DM 9 (18.4%) 10 (33.3%) 0.131
Liver impairment 4 (8.2%) 4 (13.3%) 0.460
Renal impairment 3 (6.1%) 7 (23.3%) 0.026
MODS 13 (26.5%) 26 (86.7%) <0.001
Liver 1 (2%) 5 (16.7%) 0.017
Cardiovascular 8 (16.3%) 21 (70%) <0.001
Renal 2 (4.1%) 11 (36.7%) <0.001
CNS 2 (4.1%) 2 (6.7%) 0.611
GIT 1 (2%) 0 (0%) 0.431
Chi-square test was done, P< 0.05 signiﬁcant.
There was signiﬁcant more co-morbid renal impairment in died than survived cases and there were signiﬁcant more development of MODS in
died cases during PRVC ventilation with signiﬁcant increase of cardiovascular and renal failure during PRVC.
* t-test was done, P< 0.05 signiﬁcant.
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number of cases in our work (79 cases) compared to 22 cases
in Guldager et al. [7]. Elshafey et al. [12] have found 86.66%(65/75) survival in COPD patients with ARF with the use of
PRVC mode. The higher ﬁgure of Elshafey et al. [12] com-
pared to our work and to Guldager et al. [7] could be due to
the difference in types of ventilated patients in Elshafey et al.
[12] study who have studied PRVC in COPD patients only.
In this work there were signiﬁcant improvement of arterial
blood gases after 1 h, 2 h, 2nd day and 3rd day of using PRVC
with gradual reduction of the used FiO2 in the same period. In
the same direction, Sachdev et al. [13] concluded that PRVC
had improved oxygenation with improvement of PaO2 and
PaO2/FiO2 in initial stages of ventilation.
Also, Samantaray and Hemanth [14] concluded that PRVC
improve oxygenation after cardiopulmonary bypass-induced
perfusion mismatch. Many human studies reporting an
improvement in oxygenation with PCV [15]. This can be ex-
plained by the fact that, PRVC combines the beneﬁts of decel-
erating ﬂow of PCV with a safety of a volume guarantee at a
lowest possible titrated inspiratory pressure [16]. The rise in
oxygenation can be attributed to more even distribution of
gas volume with the use of PCV [17].
In this work there were signiﬁcant improvement of PaCO2
with the use of PRVC mode in ARF cases of pulmonary dis-
eases, this was in agreement with Tiruvoipati et al. [18] who
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than volume-controlled ventilation. Alvarez et al. [19] con-
cluded that PRVC had lower peak airway pressure and slightly
better carbon dioxide clearance. On the other hand, Menzies
et al. [20] have found that the baseline PaCo2, PaO2 were
not related with weaning outcome.
In this work there were signiﬁcant more worse hypercapnia
and higher bicarbonate level at admission in died than sur-
vived cases. The higher levels of PaCO2 may be explained by
a more severe form of type II respiratory failure developed
in died patients. Hypercapnic acidosis may increase the prob-
ability of neutrophil cell death occurring via necrosis rather
than apoptosis. Neutrophil death via necrosis causes release
of intracellular contents, including harmful enzymes, which
can cause tissue destruction [21,22]. Ambrosino et al. [23]
found that lower baseline PaCo2 value and higher pH values
correlated with success. Both increase in PaCO2 and decrease
in pH may represent signs of respiratory pump insufﬁciency
and reduced alveolar ventilation, thought to be major causes
of weaning failure. On the other hand, Bouachour et al. [24]
showed that the simple weaning criteria, such as blood gases
and clinical variables, were inadequate for the prediction of
successful weaning in the COPD patients. Also, Menzies
et al. [20] found that the baseline PaCo2, PaO2 were not re-
lated with weaning outcome.
In this work there was no signiﬁcant difference in the out-
come of PRVC as regard survival between different types
and aetiologies of respiratory failure. This could be explained
according to Tehrani et al. [8] who concluded that dual closed-
loop technique has effectively controlled mechanical ventila-
tion under different test conditions. PRVC mode have been
tried in acute respiratory failure in patients with COPD [12],
ARDS [25–27], and in post-cardiac surgical patients [14] with
promising results. Meanwhile other studies found no advan-
tage for PRVC compared to VC ventilation [2,4,6].
Also in this work the number of died cases in pneumonia,
although insigniﬁcant, was higher than survived cases. This
may denote more worse prognosis of ARF due to sepsis. Gur-
sel [28] reported that community acquired pneumonia did not
reach signiﬁcant level as independent predictor of prolonged
mechanical ventilation and subsequent increased mortality.
Curley et al. [21] stated that; In early sepsis, hypercapnic acido-
sis may reduce the host inﬂammatory response and decrease
the contribution of bacterial toxin mediated injury to tissue in-
jury and damage, while late, the prolonged decrease in the host
response to bacterial infection might result in unopposed bac-
terial proliferation, thereby increasing direct bacterial tissue
invasion and injury, and worsening lung injury.
Our study revealed no signiﬁcant difference between sur-
vived and died patients regarding the age and sex. Similarly,
Nevins and Epstien [29] found that age was not an independent
predictor of outcome. Also, Ely et al. [30] concluded that the
survival rates for elderly persons on the mechanical ventilator
was similar to younger patients.
Our study observed that respiratory rate (RR) was signiﬁ-
cantly decreased after extubation in comparison to pre-intuba-
tion RR, while there was no signiﬁcant difference between
survived and died cases regarding admission RR. This was
conﬁrmed by Bouachour et al. [24], who observed that
commonly used weaning indices (RR, Vt, f/Vt ratio) were
not good predictors of weaning failure. Also, Hilbert et al.
[31] evaluated a number of variables, including RR, rapid shal-low breathing index, for the ability to predict success of extu-
bation but found none to be of any value. On the other hand,
Menzies et al. [20] observed that the higher respiratory rate
was a bad predictor for weaning success.
In present study, there was signiﬁcant more co-morbid re-
nal impairment in died than survived cases. Similarly, Nevins
and Epstien [29] concluded that, the presence of comorbidity
and a measure of the severity of the acute illness are predictors
of in-hospital mortality among patients with COPD and acute
respiratory failure. Also Gursel [28] reported that comorbidity
was signiﬁcantly associated with prolonged mechanical venti-
lation. Similarly, Antonelli et al. [32] reported the importance
of comorbidity as a predictor for the outcome of COPD
patients.
The mortality rate was signiﬁcantly increased in patients
who developed MODS in our study especially renal and
CVS failure as evidenced by lower MAP in died than survived
cases in our study. The mortality rate increase with increasing
number of organ failures [33]. Worsening MODS is a reﬂection
of worsening clinical condition that might have been affected
by an ICU event [34]. The ﬁrst evidence of organ dysfunction
is usually changes in the respiratory and cardiovascular sys-
tems. The resulting pulmonary failure and ensuing hypoxemia
are followed by hepatic and renal dysfunction and disorders of
the haemostatic, gastrointestinal and central nervous systems
[35].
The present study reported signiﬁcant increase in GCS after
extubation. Similarly, Jayamanne et al. [36] noted that MODS
and altered mental status were strongly associated with the
need for reintubation.
In this study there were signiﬁcant longer duration of
PRVC and overall mechanical ventilation days in died than
survived cases. Similarly, Nevins and Epstien [29] reported that
the early reversal of acute respiratory failure is associated with
good outcome while patients requiring prolonged MV have a
poorer prognosis. This may be explained by prolonged
mechanical ventilation and endo-tracheal intubation which
leads to impairment of the normal protective reﬂexes of the
respiratory tract with increased incidence of ventilator-associ-
ated pneumonia with a high mortality rate [37].
Admission hemoglobin was signiﬁcantly higher among sur-
vived group than died cases in present study. Also, Schonhofer
et al. [38] observed that weaning off mechanical ventilation
was not achieved until hemoglobin level of 12 g/dl were
achieved with transfused blood; blood transfusion in COPD
patients led to signiﬁcant decrease in both the minute ventila-
tion and the work of breathing. Nevins and Epstein [29] noted
that those with anemia were associated with increased mortal-
ity. These illustrate the importance of blood transfusion in
those critically ill patients with evident systemic oxygen debt.
This reﬂects the importance of correction of non-respiratory
causes of weaning failure like anemia as well as the respiratory
causes.
The present study reported signiﬁcant increase in serum
creatinine, AST and WBC in died than survived cases. Sim-
ilarly, Nikhanj et al. [39] observed that admission laboratory
data was notable for leukopenia, transaminitis and elevated
creatine kinase levels. Also, Tachypnea, leukocytosis and
presence of liver disease were signiﬁcant predictors for med-
ical ICU admission [40]. The elevated creatinine level, WBC
and AST may be attributed to more severe forms of the dis-
ease among deaths in our study and the presence of MODS,
Pressure-regulated volume controlled ventilation 157including signiﬁcant renal dysfunction during PRVC
ventilation.
Conclusion
PRVC ventilation improves oxygenation parameters in ARF
of different etiologies and is equally effective in management
of ARF of different pulmonary disorders. The most important
predictors for mortality were development of MODS and pro-
longed duration of MV as detected by logistic regression
analysis.
Recommendations
PRVC ventilation is a recent optional mode of ventilation in
ARF of pulmonary diseases. More randomized clinical trials
are required to study the efﬁcacy, safety and the preference
of PRVC mode than other modes in ARF of diseased lung.Acknowledgements
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